Etana Biotechnologies Indonesia Overview

  • Year Founded
  • 2014

Year Founded

  • Status
  • Private

  • Employees
  • 435

Employees

  • Latest Deal Type
  • Later Stage VC
  • (Upcoming)

  • Latest Deal Amount
  • $30M

  • Investors
  • 8

Etana Biotechnologies Indonesia General Information

Description

Operator of a biotech company intended to manufacture biosimilars for Indonesia and other emerging countries. The company engages in the development and commercialization of biological drugs in the oncology field and other life-threatening diseases and in the manufacturing, R&D, and marketing of recombinant gene technology and monoclonal antibody drugs, providing patients with affordable medicines and vaccines.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Kawasan Industri Pulogadung
  • Jl. Rawa Gelam V Blok L Kav. 11-13, Jatinegara, Cakung
  • East Jakarta, 13930
  • Indonesia
+62 (021)
Primary Industry
Biotechnology
Other Industries
Pharmaceuticals
Vertical(s)
Corporate Office
  • Kawasan Industri Pulogadung
  • Jl. Rawa Gelam V Blok L Kav. 11-13, Jatinegara, Cakung
  • East Jakarta, 13930
  • Indonesia
+62 (021)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Etana Biotechnologies Indonesia Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Later Stage VC $30M Upcoming Generating Revenue
3. Later Stage VC 20-Mar-2023 Completed Generating Revenue
2. Later Stage VC (Series B) 28-Sep-2022 Completed Generating Revenue
1. Later Stage VC (Series A) 14-Sep-2021 Completed Generating Revenue
To view Etana Biotechnologies Indonesia’s complete valuation and funding history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Etana Biotechnologies Indonesia Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Operator of a biotech company intended to manufacture biosimilars for Indonesia and other emerging countries. The compan
Biotechnology
East Jakarta, Indonesia
435 As of 2026

Beijing, China
 

Suzhou, China
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Etana Biotechnologies Indonesia Competitors (69)

One of Etana Biotechnologies Indonesia’s 69 competitors is BeOne Medicines, a Formerly PE-Backed company based in Beijing, China.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
BeOne Medicines Formerly PE-Backed Beijing, China
Alphamab Oncology Formerly VC-backed Suzhou, China
Genetix Biotherapeutics Private Equity-Backed Somerville, MA
AB Science Formerly Accelerator/Incubator backed Paris, France
Brii Biosciences Formerly VC-backed Beijing, China
You’re viewing 5 of 69 competitors. Get the full list »

Etana Biotechnologies Indonesia Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Etana Biotechnologies Indonesia Investors (8)

Investor Name Investor Type Holding Investor Since Participating Rounds
DEG PE/Buyout Minority
East Ventures Venture Capital Minority
China Medical System Holdings Corporation Minority
Highlight Capital Venture Capital Minority
Yunfeng Capital PE/Buyout Minority
You’re viewing 5 of 8 investors. Get the full list »

Etana Biotechnologies Indonesia FAQs

  • When was Etana Biotechnologies Indonesia founded?

    Etana Biotechnologies Indonesia was founded in 2014.

  • Where is Etana Biotechnologies Indonesia headquartered?

    Etana Biotechnologies Indonesia is headquartered in East Jakarta, Indonesia.

  • What is the size of Etana Biotechnologies Indonesia?

    Etana Biotechnologies Indonesia has 435 total employees.

  • What industry is Etana Biotechnologies Indonesia in?

    Etana Biotechnologies Indonesia’s primary industry is Biotechnology.

  • Is Etana Biotechnologies Indonesia a private or public company?

    Etana Biotechnologies Indonesia is a Private company.

  • What is Etana Biotechnologies Indonesia’s current revenue?

    The current revenue for Etana Biotechnologies Indonesia is .

  • Who are Etana Biotechnologies Indonesia’s investors?

    DEG, East Ventures, China Medical System Holdings, Highlight Capital, and Yunfeng Capital are 5 of 8 investors who have invested in Etana Biotechnologies Indonesia.

  • Who are Etana Biotechnologies Indonesia’s competitors?

    BeOne Medicines, Alphamab Oncology, Genetix Biotherapeutics, AB Science, and Brii Biosciences are some of the 69 competitors of Etana Biotechnologies Indonesia.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process